ProShare Advisors
KITE

ProShare Advisors’s Kite Pharma, Inc. KITE Stock Holding History

ProShare Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-36,796
Closed -$6.62M – 1814
2017
Q3 		$6.62M Buy
36,796
+2,390
+7% +$333K 0.06% 319
2017
Q2 		$3.57M Buy
34,406
+2,069
+6% +$169K 0.04% 427
2017
Q1 		$2.54M Sell
32,337
-7,543
-19% -$466K 0.03% 491
2016
Q4 		$1.79M Buy
39,880
+3,428
+9% +$168K 0.02% 582
2016
Q3 		$2.04M Sell
36,452
-6,347
-15% -$354K 0.03% 489
2016
Q2 		$2.14M Buy
42,799
+1,768
+4% +$86.9K 0.03% 484
2016
Q1 		$1.88M Sell
41,031
-273
-0.7% -$13.2K 0.03% 475
2015
Q4 		$2.54M Buy
41,304
+3,807
+10% +$268K 0.03% 435
2015
Q3 		$2.09M Sell
37,497
-547
-1% -$34.4K 0.03% 467
2015
Q2 		$2.32M Buy
38,044
+5,329
+16% +$304K 0.03% 460
2015
Q1 		$1.89M Buy
32,715
+5,302
+19% +$355K 0.02% 580
2014
Q4 		$1.58M Buy
+27,413
New +$1.15M 0.02% 646

ProShare Advisors's KITE Position: Q4 2017 in Review

ProShare Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 36,796 shares — an estimated $6.62M sold.

ProShare Advisors first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $6.62M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • ProShare Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • ProShare Advisors sold 36,796 Kite Pharma, Inc. shares in Q4 2017, an estimated $6.62M.
  • ProShare Advisors first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • ProShare Advisors's Kite Pharma, Inc. position peaked at $6.62M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on ProShare Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.